Imaging as an End Point in Ischemia Trials

被引：0
作者：
Howarth A.G. [1 ]
Friedrich M.G. [1 ]
机构：
[1] University of Calgary, Calgary, AB, Suite 700, SSB
来源：
Current Cardiovascular Imaging Reports | 2011年 / 4卷 / 2期
关键词：
BOLD; Cardiac computed tomography; Cardiac imaging; Cardiovascular magnetic resonance imaging; Ischemia; Perfusion; Prognosis; Sensitivity; Specificity; SPECT; Stress echocardiography; Vascular imaging;
D O I：
10.1007/s12410-011-9068-6
中图分类号：
学科分类号：
摘要：
Imaging of cardiac function and anatomy has advanced at an exponential rate over the past two decades. Our ability to quantitatively assess the degree of myocardial ischemia and accurately define the vascular anatomy using noninvasive techniques is greater than ever before. Current advances is cardiac imaging are allowing us to more safely assess patients for myocardial ischemia and better understand the prognostic implications of our findings. This review summarizes the current state of knowledge in cardiac imaging for the assessment of cardiac ischemia with a focus on the use of cardiac MRI. © 2011 The Author(s).
引用
收藏
页码：90 / 97
页数：7
相关论文
共 41 条
  • [1] Emond M., Mock M.B., Davis K.B., Et al., Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry, Circulation, pp. 2645-2657, (1994)
  • [2] Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., Berman D.S., Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography, Circulation, 107, pp. 2900-2907, (2003)
  • [3] Boden W.E., O'Rourke R.A., Teo K.K., Et al., Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, pp. 1503-1516, (2007)
  • [4] Shaw L.J., Berman D.S., Maron D.J., Et al., Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy, Circulation, pp. 1283-1291, (2008)
  • [5] Simoons M.L., Windecker S., Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization, European Heart Journal, 31, pp. 530-541, (2010)
  • [6] Tonino P., Fearon W., de Bruyne B., Et al., Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation, Journal of the American College of Cardiology, pp. 2816-2821, (2010)
  • [7] Shaw L., Prognostic value of gated myocardial perfusion SPECT, Journal of Nuclear Cardiology, pp. 171-185, (2004)
  • [8] Marwick T., Shan K., Patel S., Go R.T., Lauer M.S., Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease, Am J Cardiol, 80, (1997)
  • [9] Schwitter J., Wacker C., van Rossum A., Et al., MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial, European heart journal, (2008)
  • [10] Hamon M., Fau G., Nee G., Ehtisham J., Morello R., Hamon M., Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease, Jcmr, 12, (2010)
12345